Session Information
Date: Wednesday, June 22, 2016
Session Title: Parkinson's disease: Cognition
Session Time: 12:00pm-1:30pm
Location: Exhibit Hall located in Hall B, Level 2
Objective: To develop and evaluate motor-free procedures via eye tracking for determining cognitive functions in patients with idiopathic Parkinson’s disease (PD) and motor neuron disease (MND).
Background: Many recognized measurements and survey methods to study cognitive functions are based on written/oral in-/output. As a result, the assessment of patients with advanced neurodegenerative diseases such as PD and MND is often limited due to motor impairments.
Methods: We implemented an established "paper-pencil" test (Trail Making Test, Raitan, 1979) for measuring attention (TMT-A) and executive functions (TMT-B) in a special eye tracking software (eTMT). Precision and performance results of PD and MND patients as well as healthy controls (C) were evaluated. Patients were dichotomized either according to above- and below-average ALSFRS-R scores (MND+/MND-) or Hoehn & Yahr scores (≥3: PD-/<3: PD+), respectively. Age, education, wellbeing and personality were assessed as control variables.
Results: 21 subjects with PD, 28 subjects with MNDs and 18 control subjects completed the assessment. 11 severely affected ALS patients (ALS-) were unable to perform the written TMT. Demographic analyses only revealed slight age differences (p.047). Among all groups, the obtained fixation data neither revealed differences in accuracy (p=.06) nor in the relevant eTMT processing times (eTMT-A: p=.31; eTMT-B: p=.09). The age-corrected partial correlations between the TMT-A and eTMT-A (r=.369, p=.05) as well as the TMT-B and eTMT-B (r=.631, p<.001) were significant across all subjects. Differences between subgroups became apparent in the number of fixations per second and written TMT processing times.
Conclusions: The results confirm a high accuracy of the method and indicate a sufficient overlap of each assessed construct. Thus, eye tracking is suitable for the measurement of cognitive performance in patients with neurodegenerative diseases and motor restrictions.
DGN 2015, Duesseldorf, Germany.
To cite this abstract in AMA style:
H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann. Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/eye-tracking-based-measurement-of-cognitive-functions-in-patients-with-neurodegenerative-diseases/. Accessed November 22, 2024.« Back to 2016 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/eye-tracking-based-measurement-of-cognitive-functions-in-patients-with-neurodegenerative-diseases/